Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures
EMA’s safety committee (PRAC) is recommending precautionary measures for the treatment of male patients with valproate medicines.
News
Human
Pharmacovigilance
Referrals